EMBARC is delighted to announce the launch of the new European Registry for Non-tuberculous Mycobacteria Pulmonary Disease (NTM-PD). The first meeting of the steering committee took place in Milan on …

The new Bronchiectasis Guidelines will be released next week during the annual European Respiratory Society conference.

Join us on Sunday at 14:45 to hear more about the guidelines and have your …

Congratulations to everyone involved in the organisation of the second World Bronchiectasis Conference in the beautiful setting of Milan. WBC has yet again proved another success with great …

EMBARC and IRIDE are offering two free places to the 2nd World Bronchiectasis Conference. For a chance to win one of these places, applications should be emailed to info@bronchiectasis.eu outlining …

The 2nd Word Bronchiectasis Conference will be held in Milan this summer. We are still keen to receive more abstracts before 8th May, the best abstracts will be published in Multidisciplinary …

It is with great sadness that we share with you the news that our friend and collaborator, John W Walsh has passed away. John was a tireless advocate for better patient care and research in Alpha-1- …

The impact of comorbidities in bronchiectasis has been poorly understood until now. A group of EMBARC investigators have highlighted the key roles and therefore the impact multimorbidity has on …

The United States Bronchiectasis Research Registry have released the findings from over 1800 bronchiectasis patients enrolled from 13 centres across the US.

Have a look at the accepted manuscript …

Members of the EMBARC Network will be presenting registry data during the European Respiratory Society conference in London next month. We encourage everyone to join us on Sunday morning to see Dr …

EMBARC travel to Hannover today to attend the 1st World Bronchiectasis Conference in Germany. The conference is being held over three days in the newly restored historical Herrenhausen Palace and …

Now published online in the European Respiratory Journal, an EMBARC working group has published a list of 22 key recommendations for future research into bronchiectasis. This project involved a …

Congratulations to EMBARC investigators and members from 23 countries who have contributed to achieving the 2000th patient enrolled. This greatly exceeds our targets for the first year of recruitment. …

With updates on recruitment progress, and a welcome to our new investigators and information about frequently asked questions. Download the newsletter Download January 2016-2

EMBARC has made all of the information about the design and conduct of the European Bronchiectasis Registry publically available through a new publication in The European Respiratory Journal Open …

EMBARC seeks to encourage applications to the ERS fellowship programme in the exciting field of bronchiectasis research. The European Respiratory Society provides fellowships to support young …

View two presentations from the European Respiratory Society congress, including the first results from the EMBARC registry in our round-up of the ERS 2015 highlights and the EMBARC symposium - www. …

The first results of the EMBARC registry were announced at the beginning of October at the ERS congress in Amsterdam. Thanks to the dedication of all of the clinicians, nurses and allied health …

The ERS congress has started with a number of contributions on bronchiectasis from researchers from EMBARC and partners. We are delighted to see so many participants at the oral presentation and …

At Congress, the Healthy Lungs for Life campaign will launch its new theme: Take the Active Option. We think this campaign offers a great opportunity to raise awareness of the role of physical …

EMBARC is contributing to a €50 million, Europe-wide, project to develop new drugs that could improve the lives of patients with cystic fibrosis and bronchiectasis.

The iABC (inhaled …

EMBARC will be working hard to promote bronchiectasis at the upcoming ERS congress in Amsterdam. Learn more about EMBARC and get involved in the project at Congress.

Visit the EMBARC stand in the …

A new Cochrane review on the effectiveness of prolonged antibiotics was published today

The review highlighted the paucity of data in bronchiectasis, identifying few trials and only 1157 patients …

The European Respiratory Society Congress in Amsterdam is showcases a wealth of information on all aspects of respiratory health and disease. We are delighted that the first results of the European …

A new study in Thorax makes a further contribution to understanding how frequently bronchiectasis may complicate COPD. This study Suggests that the frequency of bronchiectasis in patients without a …

The 1st World Bronchiectasis Conference is an initiative of EMBARC, the European Bronchiectasis Registry. It is the first conference focusing solely on bronchiectasis. Visit the website at http:// …

Interesting new research from Brazil finds that in asymptomatic elderly never smokers, bronchiectasis may be a "normal" finding in nearly 20% of cases.

19.1% of over-75's undergoing an HRCT scan had …

Congratulations to investigators from the initial pilot sites in the European Bronchiectasis Registry. Recruitment has reached more than 200 patients in less than 2 months of recruitment. …

Help set the agenda by telling us what new treatments and improvements in care you want to see for patients with bronchiectasis. The European lung foundation (ELF) is running a survey for people with …

Help to set the agenda by telling us what new treatments and improvements in care you want to see for patients with bronchiectasis. The European lung foundation is running a patient survey for …

The European bronchiectasis registry is now open for recruitment. To register to participate, please register via the following link - www.bronchiectasis.eu/register

Its easy to register to take …

The European Respiratory Society has announced the formation of a task force to develop guidelines for the management of patients with bronchiectasis. The two year project will develop the first …

Queens University Belfast is offering a fully funded 3 years fellowship in bronchiectasis clinical trials. Medical trainees from any country interested in bronchiectasis or cystic …

This week sees the publication of two large phase III randomized controlled trials of inhaled aztreonam in bronchiectasis. The global studies investigated whether patients with chronic Gram-negative …

 A record number of abstracts featuring bronchiectasis are presented the ERS 2014 meeting. Below is a list of some of the key sessions featuring bronchiectasis abstracts

Room B2-1 …

Congratulations to EMBARC's Felix Ringshausen for today winning the ERS best abstract award for his study

"Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis"

The …

The European Bronchiectasis Network (EMBARC) seeks to promote clinical research in bronchiectasis and to build research capacity in Europe. A key task in this will be identifying the areas of …

The EMBARC registry is now open for registration. Centres are able to sign up to participate in the EU wide registry of non-CF bronchiectasis. Instructions on how to register and to access the CRF …

International bronchiectasis researchers reported new data at the American Thoracic Society 2014 conference last week, with important new work in bronchiectasis reported. Highlights of two …

A randomized controlled trial from investigators in Australia suggests that 8 weeks of supervised exercise training can reduce the frequency of exacerbations in patients with bronchiectasis. Previous …

The European Respiratory Society has recognised EMBARC by awarding the European Bronchiectasis Network status as an official Clinical Research Collaboration (CRC). The three year partnership with the …

Over 100 investigators and centres in 21 countries have now joined the EMBARC network. The participation of so many enthusiastic researchers across Europe will ensure the success of the EMBARC …